BCPEMI
DNA icon

Bain Capital Public Equity Management II’s Ginkgo Bioworks DNA Stock Holding History

Bain Capital Public Equity Management II’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-75,975
Closed -$35.2M – 49
2021
Q3 		$35.2M Buy
+75,975
New +$37M 1.23% 27

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bain Capital Public Equity Management II's DNA Position: Q4 2021 in Review

Bain Capital Public Equity Management II sold out of Ginkgo Bioworks (DNA) in Q4 2021, closing a stake of 75,975 shares — an estimated $35.2M sold.

Bain Capital Public Equity Management II first reported a position in DNA in Q3 2021 and held it in 1 quarter. The position peaked at $35.2M in Q3 2021. 164 funds tracked by Wall St. Rank hold DNA as of Q4 2021.

  • Bain Capital Public Equity Management II reported no remaining Ginkgo Bioworks position as of Q4 2021 after selling out during the quarter.
  • Bain Capital Public Equity Management II sold 75,975 Ginkgo Bioworks shares in Q4 2021, an estimated $35.2M.
  • Bain Capital Public Equity Management II first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 1 quarter.
  • Bain Capital Public Equity Management II's Ginkgo Bioworks position peaked at $35.2M in Q3 2021.
  • 164 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2021.

Based on Bain Capital Public Equity Management II's 13F filing for Q4 2021, filed 14 Feb 2022.